Clinical trial
Pilot Study of Zoledronic Acid in Combination With First-line Chemotherapy in Aged Patients With Lung Cancer
NCT01737216 is registered in ClinicalTrials.gov with Hebei Tumor Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Study of Zoledronic Acid in Combination With First-line Chemotherapy in Aged Patients With Lung Cancer
- Lead sponsor
- Hebei Tumor Hospital
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- November 30, 2012
- Completion date
- December 31, 2016
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lung cancer